Possible mechanism of selective inotropic activity of the n-butanolic fraction from Berberis aristata fruit

General Pharmacology

Volumn 33, Issue 5, 1999, Pages 407-414

  Gilani, Anwar H ^a   Janbaz, Khalid H ^b   Aziz, Nauman ^a   Herzig, Marcus J U ^a   Kazmi, Murtaza M ^a   Choudhary, M I ^c   Herzig, Joachim W ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Actin myosin interaction; Berberis aristata; cAMP; Cardiotonic agent; n Butanolic fraction; Skinned fibers

Indexed keywords

BERBERIS ARISTATA EXTRACT; CALCIUM; CARDIOTONIC AGENT; CYCLIC AMP; ISOPRENALINE; PLANT EXTRACT; PROPRANOLOL; UNCLASSIFIED DRUG;

ACTIN MYOSIN INTERACTION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FRACTIONATION; GUINEA PIG; HEART ATRIUM; HEART VENTRICLE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; SKINNED MUSCLE FIBER;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM; CARBACHOL; CARDIOTONIC AGENTS; CYCLIC AMP; FEMALE; FRUIT; GUINEA PIGS; HEART; HEART ATRIA; HEART VENTRICLES; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; PLANTS, MEDICINAL; PROPRANOLOL; RESERPINE; TIME FACTORS;

EID: 0032753185     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(99)00035-X     Document Type: Article

References (24)

1. Braithwaite A., Smith F.J. Chromatographic methods. 4th edition:1985;Chapman and Hall, London.
2. Endoh M. The time course of changes in cyclic nucleotide levels during cholinergic inhibition of positive inotropic actions of isoprenaline and theophylline in the isolated canine ventricular myocardium. Naunyn-Schmiedeberg's Arch Pharmacol. 312:1980;175-182.
3. England P.J., Shahid M. Effects of forskolin on contractile response and protein phosphorylation in the isolated perfused rat heart. Biochem J. 246:1987;687-695.
4. Erdmann E. The value of positive inotropy in acute and chronic heart failure. J Cardiovasc Pharmacol. 14(suppl. 3):1989;S36-S41.
5. Fabiato A. Myoplasmic free calcium ion concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol. 78:1981;457-497.
6. Francis G.S., Cohn J.N. Heart failure. mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention FASEB J. 4:1990;3068-3075.
7. Gilani A.H., Janbaz K.H. Prevention of acetaminophen-induced liver damage by Berberis aristata leaves. Biochem Soc Trans. 20:1992;347.
8. 4-induced hepatotoxicity. Phytother Res. 9:1995;489-494.
9. Gilani A.H., Shaheen F. Vasoconstrictor and cardiotonic actions of Haloxylon recurvum extract. Phytother Res. 8:1994;115-117.
10. Herold P., Herzig J.W., Wenk P., Leutert T., Zbinden P., Fuhrer W., Stutz S., Schenker K., Meier M., Rihs G. 5-Methyl-6-phenyl 1, 3, 5, 6-tetrahydro-3, 6-methano-1, 5-benzodiazocine-2,4-dione (BA 41899). representative of a novel class of purely calcium-sensitizing agents J Med Chem. 38:1995;2946-2954.
11. Herzig J.W., Chiesi M., Depersin H., Gruninger S., Hasenfuss G., Kubalek R., Leutert T., Pieske B., Pioch K., Wenk P., Holubarsch C. Ca sensitization in idiopathic dilated human myocardium. Arzneim Forsch Drug Res. 46:1996;586-593.
12. Herzig J.W., Feile K., Ruegg J.C. Activating effects of AR-L 115 BS on the calcium sensitive force, stiffness and unloaded shortening velocity in isolated contractile structures from mammalian heart muscle. Arzneim Forsch Drug Res. 31:1981;188-191.
13. Hoffman B.B., Lefkowitz R.J. Adrenergic receptor antagonists. Gilman A.G., Rall T.W., Nies A.S., Taylor P. The Pharmacological basis of therapeutics. 8th edition:1990;221-243 Pergamen Press, New York. a.
14. Hoffman B.B., Lefkowitz R.J. Catecholamines and sympathomimetic drugs. Gilman A.G., Rall T.W., Nies A.S., Taylor P. The Pharmacological basis of therapeutics. 8th edition:1990;187-220 Pergamen Press, New York. b.
15. Katz A.M. Potential deleterious effects of inotropic agents in the therapy of congestive heart failure. Circulation. 73(suppl. III):1986;III184-III190.
16. Lang R.M., Fellner S.K., Neumann A., Bushinsky D.A., Borow K.M. Left Ventricular contractility varies directly with blood ionized calcium. Ann Intern Med. 108:1988;524-529.
17. Leijendekker W.J., Herzig J.W. Reduction of myocardial cross-bridge turnover rate in presence of EMD 53998, a novel calcium sensitizing agent. Pfluger Arch Eur J Physiol. 421:1992;388-390.
18. Nadkarni K.M. Indian materia medica. 1976;Popular Prakashan, Bombay.
19. Packer M. Vasodilator and inotropic drugs for the treatment of chronic heart failure. distinguishing hype from hope J Amer Coll Cardiol. 12:1988;1299-1317.
20. Perrin D.D., Sayce I.G. Computer calculation of equilibrium concentrations in mixtures of metal ions and complexing species. Talanta. 14:1967;833-842.
21. Salzmann R., Bormann G., Herzig J.W., Markstein R., Scholtysik G. Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol. 7:1985;588-596.
22. Siegl P.K.S. Overview of cardiac inotropic mechanisms. J Cardiovasc Pharmacol. 8(suppl. 9):1986;S1-S10.
23. Sys S.U., Boels P.J., Brutsaert D.L. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart. J Cardiovasc Pharmacol. 10:1987;445-449.
24. Zimmermann N., Boknik P., Gams E., Herzig J.W., Neumann J., Schmitz W., Scholz H., Wenzlaff H. Positive Inotropic effects of the calcium sensitizer CGP 48506 in guinea-pig myocardium. J Pharmacol Exp Ther. 277:1996;1572-1578.